LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
1-Year Est. Return 2.97%
This Quarter Est. Return
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$153M
AUM Growth
+$32.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

1
+$13.1M
2
+$11.5M
3
+$2.23M
4
CGEM icon
Cullinan Oncology
CGEM
+$1.24M
5
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$1.05M

Top Sells

1
+$6.24M
2
+$4.79M
3
+$3.53M
4
PASG icon
Passage Bio
PASG
+$2.11M
5
CBAY
Cymabay Therapeutics
CBAY
+$1.81M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$30.3M 19.88%
1,152,525
+84,802
2
$28.2M 18.45%
2,181,377
-273,250
3
$27.5M 17.99%
2,670,472
-465,701
4
$13.2M 8.65%
1,205,050
-164,877
5
$13.1M 8.56%
+5,224,600
6
$11.5M 7.54%
+969,374
7
$7.06M 4.63%
3,902,434
+578,373
8
$7.06M 4.63%
757,009
-4,249
9
$6.21M 4.07%
2,048,736
-165,514
10
$2.57M 1.68%
154,728
+33,312
11
$1.62M 1.06%
122,198
+33,852
12
$1.24M 0.81%
+115,063
13
$1.1M 0.72%
58,367
-112,013
14
$956K 0.63%
23,000
15
$571K 0.37%
+193,573
16
$321K 0.21%
21,225
-5,000
17
$167K 0.11%
+20,114
18
$34.7K 0.02%
+1,827
19
– –
-866,646